Chromocell Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · IEX Real-Time Price · USD
1.110
-0.040 (-3.48%)
At close: Jul 19, 2024, 4:00 PM
1.120
+0.010 (0.90%)
Pre-market: Jul 22, 2024, 4:27 AM EDT
Chromocell Therapeutics Market Cap
Chromocell Therapeutics has a market cap or net worth of $6.40 million as of July 22, 2024.
Market Cap
6.40M
Enterprise Value
2.63M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since the IPO on February 16, 2024, Chromocell Therapeutics's market cap has decreased from $33.50M to $6.40M, a decrease of -80.90%. That is a compound annual growth rate of -98.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 6.40M | -80.90% |
| Feb 16, 2024 | 33.50M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alaunos Therapeutics | 6.76M |
| Tenax Therapeutics | 6.70M |
| NuCana | 6.69M |
| Telesis Bio | 6.69M |
| Xenetic Biosciences | 6.41M |
| ReShape Lifesciences | 6.21M |
| Pasithea Therapeutics | 6.10M |
| CareMax | 6.01M |